Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter β΅ to start review
Explore by Goal
"The scientist is not a person who gives the right answers, he's one who asks the right questions."
This 2025 systematic review argues that gluten exposure plus genetic susceptibility (HLA-DQ2/DQ8) plus other factors (e.g., microbiota) drive celiac disease, and summarizes epidemiology, diagnosis, and a list of non-HLA loci; however, the provided full text indicates a largely qualitative synthesis with limited reporting on PRISMA-like rigor, study quality assessment, and quantitative meta-analysis methods.
Jump to deeper sections: epidemiology, immune-mechanism map, genetics landscape, and methodological critique.
Long Answer
Paper Review (visual + critical): Pathogenesis and genetics of celiac disease; a systematic review
Type: Systematic review (qualitative synthesis as described in the provided full text)
| Claimed coverage: 2000β2024; English-language; databases: PubMed, Scopus, Google Scholar; included studies: 63
1) What the review claims (and what is actually shown)
Core causal framing: celiac disease is βimmune mediated,β triggered by gluten ingestion in genetically predisposed individuals, with contributions from intestinal microbiota and genetic influences.
Genetic emphasis: HLA-DQ2/DQ8 account for βapproximately 40%β of incidence, plus βover 100β non-HLA genes linked via GWAS.
Diagnostics snapshot: it reports tTG IgA sensitivity 85β95% and specificity 95β99%, and EmA specificity 99β100% with sensitivity 95β100% (as presented in the diagnostic section).
Key skepticism: the provided review text (as received here) emphasizes qualitative synthesis but does not show (within the provided excerpt) PRISMA flow details, formal risk-of-bias assessment, or quantitative pooling. That reduces confidence in any specific numeric claims beyond what is explicitly cited.
2) Visual: reported prevalence values (from the paperβs Table 1)
The review includes numeric prevalence values and at-risk-group prevalence in its Table 1; only the values visible in the provided full text are used below.
Interpretation limits: regional prevalence estimates are highly sensitive to screening strategy, diagnostic confirmation (serology vs biopsy), and case-finding intensity. The paper itself notes prevalence can vary βacross specific geographical areas.β
3) Visual: diagnostic test performance ranges (as reported)
This chart plots the ranges the review reports for tTG IgA and EmA (sensitivity/specificity).
Skeptical note: these performance figures are not stratified by patient age, disease stage, IgA deficiency status, assay generation, or reference standards. The paper itself also provides evidence that serology can miss some patients (in its references), which implies performance varies in practice.
Constructed only from statements present in the provided full text (gluten trigger; HLA-DQ2/DQ8; T cell activation; IFN-Ξ³ and IL-15; villous atrophy/crypt hyperplasia; microbiota as contributory factor).
Direct evidence anchors: The review describes adaptive immunity activation with IFN-Ξ³ and innate immune involvement featuring IL-15, leading to villous atrophy and crypt hyperplasia.
5) Genetics landscape: HLA vs non-HLA (data extraction from Table 2 in the provided text)
Below is a compact table built from the gene names and categories shown in Table 2 of the provided full text (non-HLA regions and genes).
Negative regulation of cytokine signaling; germ cell development
21q22
UBASH3A
T-cell signaling and T-cell apoptosis
Xq28
IRAK1
NF-ΞΊB signaling
21q22.3
ICOSLG
Cell adhesion molecules
Critical interpretation: A list of loci/genes does not establish mechanism by itself. Many loci cluster in immune regulation pathways (T-cell activation, JAK-STAT, NF-ΞΊB, chemokine signaling), but the review does not quantify effect sizes, replication across ancestries, or functional validation for each locus in the provided excerpt.
The existence of numerous non-HLA loci is consistent with broader genomics literature summarized by the paper, e.g., work linking celiac loci to immune gene expression.
6) Methodological critique (based strictly on whatβs visible in the provided full text)
Strengths seen in the provided text
Clear topic framing: includes epidemiology, diagnosis, pathophysiology, and genetics with emphasis on HLA and non-HLA loci.
Search databases named and time window (2000β2024) provided.
Red flags / uncertainty sources
Language restriction (English-only) can systematically omit relevant studies, potentially skewing effect estimates and mechanistic emphasis. The provided Methods explicitly states inclusion of English language studies.
No explicit quantitative meta-analysis is shown in the provided excerpt; it presents a qualitative βreview of 63 studiesβ and makes numeric claims (e.g., HLA accounts for ~40%) without showing how those numbers were pooled.
Selection bias: the excerpt says articles are included if titles/abstracts include relevant keywords; this can create framing bias and miss studies where relevant terms are absent from abstracts.
Heterogeneity of diagnostic standards: serology sensitivity/specificity vary by assay platform and patient context; the review provides ranges, but without stratification. Additionally, a referenced meta-analysis indicates serology can miss many cases with persistent villous atrophy on a gluten-free dietβmeaning diagnostic performance is context dependent.
What would most improve confidence scientifically
Include a PRISMA-style flow diagram, explicit inclusion/exclusion criteria details, and risk-of-bias assessment method for included studies.
Clarify whether numeric values (e.g., β~40% incidence explained by HLAβ) are derived from a specific estimator, a single study, or a composite across studies.
Quantify heterogeneity and perform meta-analysis where feasible (or clearly state why not).
Immune activation + cytokine effects are described: gliadin presented via HLA-DQ2/DQ8 to CD4+ T cells with cytokines including IFN-Ξ³; IL-15 involvement; outcome includes villous atrophy and crypt hyperplasia.
Plausible/inferred (not proven in the excerpt)
Microbiota as a contributor is stated, but the excerpt does not provide mechanistic causality or directionality consistency; it cites associations of taxa changes (e.g., increased Clostridium, Prevotella, Actinomyces; decreased Lactobacillus) and links to infections.
Uncertain / what could change conclusions
If future work shows that key numeric summaries (e.g., βHLA explains ~40% of incidenceβ) are not stable across cohorts/ancestries or are sensitive to diagnostic/estimation definitions, the strength of the genetic-attribution framing would weaken.
If microbiota associations remain inconsistent after rigorous controlling for diet changes and confounders, the microbiota contribution may be downgraded from causal to correlational (or context-specific). The review itself does not provide causality tests.
Where to go next on BGPT
Feedback:
Updated: April 09, 2026
BGPT Paper Review
Study Novelty
50%
The review largely synthesizes established immunology/genetics concepts for celiac disease (gluten-triggered, HLA-DQ2/DQ8 central, plus non-HLA loci and microbiota associations); novelty is limited unless the review adds new quantitative synthesis or mechanistic integration beyond what is already broadly known in earlier reviews.
Scientific Quality
60%
Scientific quality is constrained by the amount of methodological detail shown in the provided text: the excerpt specifies databases, keywords, inclusion/exclusion at a high level, and reports included study count, but does not visibly include PRISMA flow, risk-of-bias assessment, or whether/how numeric claims were pooled. Evidence strength is therefore moderate-to-weak for specific quantitative attributions.
Study Generality
70%
The topic is broad (epidemiology + diagnosis + pathogenesis + genetics) and therefore broadly informative to new entrants, but the depth appears uneven (not fully shown mechanistic quantification or genome-wide functional mapping in the excerpt).
Study Usefulness
70%
Useful as a structured overview and gene-locus primer, especially for HLA/non-HLA categorization and for a quick epidemiology/diagnostic context; less useful for mechanistic inference or for decision-grade quantitative estimates due to limitations in shown synthesis methods.
Study Reproducibility
40%
Reproducibility of the review process is limited in the provided excerpt: while databases/time window and broad criteria are described, key details (full query strings, PRISMA checklist adherence, risk-of-bias tool, and explicit pooling/analysis strategy) are not shown.
Explanatory Depth
60%
The paper provides a coherent immune-mechanistic narrative (HLA presentation β T cell activation β IFN-Ξ³/IL-15 β villous damage) and enumerates immune-regulatory genes/loci. However, functional causal depth for each gene/locus is not established in the excerpt and quantitative pathway integration is limited.
Extract Table 2 non-HLA loci and map each gene to pathway categories (NF-ΞΊB, JAK-STAT, T-cell signaling, chemokine) and generate an evidence-weighted pathway network from the reviewβs gene-function annotations.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
βMicrobiota changes are the primary cause of celiac diseaseβ is less supported here because the review frames gluten + genetic predisposition as primary and microbiota as contributory; without causal testing, causality could be reversed or confounded.
βHLA alone explains most of the diseaseβ is weakened by the reviewβs own claim of >100 non-HLA genes and by the general expectation that complex polygenic architecture extends beyond MHC contributions; the missing derivation for the ~40% figure further limits confidence.
Quick Answer
Long Answer
Top Data Sources
ExportMCP
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
